Expression of RNA CCUG repeats dysregulates translation and degradation of proteins in myotonic dystrophy 2 patients.

Myotonic dystrophy 2 (DM2) is a multisystem skeletal muscle disease caused by an expansion of tetranucleotide CCTG repeats, the transcription of which results in the accumulation of untranslated CCUG RNA. In this study, we report that CCUG repeats both bind to and misregulate the biological functions of cytoplasmic multiprotein complexes. Two CCUG-interacting complexes were subsequently purified and analyzed. A major component of one of the complexes was found to be the 20S catalytic core complex of the proteasome. The second complex was found to contain CUG triplet repeat RNA-binding protein 1 (CUGBP1) and the translation initiation factor eIF2. Consistent with the biological functions of the 20S proteasome and the CUGBP1-eIF2 complexes, the stability of short-lived proteins and the levels of the translational targets of CUGBP1 were shown to be elevated in DM2 myoblasts. We found that the overexpression of CCUG repeats in human myoblasts from unaffected patients, in C2C12 myoblasts, and in a DM2 mouse model alters protein translation and degradation, similar to the alterations observed in DM2 patients. Taken together, these findings show that RNA CCUG repeats misregulate protein turnover on both the levels of translation and proteasome-mediated protein degradation.

[1]  D. Dickenson Good science and good ethics: why we should discourage payment for eggs for stem cell research , 2009, Nature Reviews Genetics.

[2]  J. Albrecht,et al.  Ectopic expression of cyclin D3 corrects differentiation of DM1 myoblasts through activation of RNA CUG-binding protein, CUGBP1. , 2008, Experimental cell research.

[3]  J. Hershey,et al.  Age-specific CUGBP1-eIF2 Complex Increases Translation of CCAAT/Enhancer-binding Protein β in Old Liver* , 2006, Journal of Biological Chemistry.

[4]  M. Mahadevan,et al.  Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy , 2006, Nature Genetics.

[5]  M. Swanson,et al.  Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. , 2006, Human molecular genetics.

[6]  B. Schoser,et al.  DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression. , 2006, Human molecular genetics.

[7]  A. Méreau,et al.  Mammalian CELF/Bruno-like RNA-binding proteins: molecular characteristics and biological functions. , 2006, Biochimie.

[8]  Huda Y. Zoghbi,et al.  Diseases of Unstable Repeat Expansion: Mechanisms and Common Principles , 2005, Nature Reviews Genetics.

[9]  T. Cooper,et al.  Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. , 2005, Human molecular genetics.

[10]  L. Ranum,et al.  Myotonic dystrophy: RNA pathogenesis comes into focus. , 2004, American journal of human genetics.

[11]  Roma H. Patel,et al.  Overexpression of CUG Triplet Repeat-binding Protein, CUGBP1, in Mice Inhibits Myogenesis* , 2004, Journal of Biological Chemistry.

[12]  A. Goldberg Protein degradation and protection against misfolded or damaged proteins , 2003, Nature.

[13]  W. Hauswirth,et al.  A Muscleblind Knockout Model for Myotonic Dystrophy , 2003, Science.

[14]  Mariette Schrier,et al.  The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome. , 2003, Human molecular genetics.

[15]  T. Cooper,et al.  Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. , 2002, Molecular cell.

[16]  F. Hartl,et al.  Molecular Chaperones in the Cytosol: from Nascent Chain to Folded Protein , 2002, Science.

[17]  A. Delacourte,et al.  Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. , 2001, Human molecular genetics.

[18]  L. Timchenko,et al.  Molecular Basis for Impaired Muscle Differentiation in Myotonic Dystrophy , 2001, Molecular and Cellular Biology.

[19]  S. Naylor,et al.  Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9 , 2001, Science.

[20]  R. J. White,et al.  Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. , 2000, Science.

[21]  B. Byrne,et al.  Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy , 2000, The EMBO journal.

[22]  A. Leutz,et al.  Translational control of C/EBPalpha and C/EBPbeta isoform expression. , 2000, Genes & development.

[23]  T. Cooper,et al.  Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. , 1998, Science.

[24]  M. Swanson,et al.  Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. , 1996, Nucleic acids research.

[25]  P. Detloff,et al.  In vitro synthesis and cloning of long CAG repeats. , 1996, BioTechniques.

[26]  E. Hoffman,et al.  Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation. , 1995, Human molecular genetics.

[27]  C. Amemiya,et al.  Cloning of the essential myotonic dystrophy region and mapping of the putative defect , 1992, Nature.

[28]  Zeliha Ünlü Myotonic dystrophy , 1981, The Ulster Medical Journal.

[29]  A. Leutz,et al.  Translational control of C/EBP (cid:1) and C/EBP (cid:2) isoform expression , 2000 .

[30]  C. Caskey,et al.  Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy. , 1996, Human molecular genetics.